Treatment Outcome on Restenosis after Percutaneous Transluminal Coronary Angioplasty Experience Treated with Fufangshuizhijing Capsule

Abstract:

To observate the clinical effect of Fufangshuizhijing Capsule treating restenosis after Percutaneous transluminal coronary angioplasty, the results showed significant change of TG Level and LDL-C level with Fufangshuizhijing capsule orally, but no significant change for total cholesterol level. The capsule is also better for improving HRV and heart function, especially, left ventricular ejection fraction and coronary vessels disease.